Synthesis of oligosaccharides from terminal B. pertussis LPS pentasaccharide and definition of the minimal epitope recognized by anti-pertussis antibodies-Reference-Cited by-同舟云学术

Synthesis of oligosaccharides from terminal B. pertussis LPS pentasaccharide and definition of the minimal epitope recognized by anti-pertussis antibodies

Published:2024-07-24 Issue: Volume: Page:
ISSN:0282-0080
Container-title:Glycoconjugate Journal
language:en
Short-container-title:Glycoconj J

Author:

Chen Guang-wu,Guo Lina,Huang Jiasheng,Ma. Haijun,Fernandez-Castillo Sonsire,Soubal-Mora Jean Pierre,Valdes-Balbin Yury,Verez-Bencomo Vicente

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10719-024-10160-z.pdf

Reference35 articles.

1. World Health Organization. Diphtheria tetanus toxoid and pertussis (DTP) vaccination coverage Available from: https://immunizationdata.who.int/global/wiise-detail-page/diphtheria-tetanus-toxoid-and-pertussis-(dtp)-vaccination-coverage?CODE=Global&ANTIGEN=DTPCV1&YEAR=. Accessed Jan 2024

2. World Health Organization: Pertussis vaccines: WHO position paper – August 2015. WHO Weekly epidemiological record 90, 433–460 (2015)

3. Esposito, S., Stefanelli, P., Fry, N.K., Fedele, G., He, Q., Paterson, P., Tan, T., Knuf, M., Rodrigo, C., Weil Olivier, C., et al.: Pertussis prevention: reasons for resurgence, and differences in the current acellular pertussis vaccines. Front. Immunol. 10, 1344 (2019)

4. Warfel, J.M., Zimmerman, L.I., Merkel, T.J.: Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc. Natl. Acad. Sci. U.S.A. 111, 787–792 (2014)

5. Wilk, M.M., Borkner, L., Misiak, A., Curham, L., Allen, A.C., Mills, K.H.G.: Immunization with whole cell but not acellular pertussis vaccines primes CD4 T RM cells that sustain protective immunity against nasal colonization with Bordetella pertussis. Emerg. Microbes Infect. 8, 169–185 (2019)